Evidence map›Paper›PMID 36216401›Full record

ArticleBMJ open respiratory research2022

Patient survey examining the experience of care of a hospital-based opt-out tobacco dependency treatment service (the CURE Project).

Lynn Hryhorskyj, Freya Howle, Kathryn Groom, Ryan Moore, Hannah Clegg, David Shackley, Cheryl Pearce, Monique Baugh, Michael Rutherford, Helen Huddart and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open respiratory research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Lynn HryhorskyjCheadle Medical Practice, Cheadle, UK lynn.hryhorskyj1@nhs.net.
Freya HowleThe CURE Project Team, Greater Manchester Cancer Alliance, Greater Manchester Strategic Health Authority, Manchester, UK.
Kathryn GroomThe CURE Project Team, Greater Manchester Cancer Alliance, Greater Manchester Strategic Health Authority, Manchester, UK.
Ryan MooreThe CURE Project Team, Greater Manchester Cancer Alliance, Greater Manchester Strategic Health Authority, Manchester, UK.
Hannah CleggThe CURE Project Team, Greater Manchester Cancer Alliance, Greater Manchester Strategic Health Authority, Manchester, UK.
David ShackleyThe CURE Project Team, Greater Manchester Cancer Alliance, Greater Manchester Strategic Health Authority, Manchester, UK.
Cheryl PearceThe CURE Project Team, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Monique BaughThe CURE Project Team, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Michael RutherfordThe CURE Project Team, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Helen HuddartThe CURE Project Team, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Alyshia MawsonThe CURE Project Team, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Emily ManleyThe CURE Project Team, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Kath HewittThe CURE Project Team, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Jane CoyneMake Smoking History Regional Tobacco Control Programme, Greater Manchester Strategic Health Authority, Manchester, UK.
Elizabeth BenbowMake Smoking History Regional Tobacco Control Programme, Greater Manchester Strategic Health Authority, Manchester, UK.
Andrea CrossfieldMake Smoking History Regional Tobacco Control Programme, Greater Manchester Strategic Health Authority, Manchester, UK.
Rachael L MurrayDivision of Epidemiology and Public Health, UK Centre for Tobacco and Alcohol Studies, University of Nottingham, Nottingham, UK.
Matthew EvisonThe CURE Project Team, Greater Manchester Cancer Alliance, Greater Manchester Strategic Health Authority, Manchester, UK.ORCID 0000-0003-4066-5253
Manchester University NHS Foundation Trust · GBGreater Manchester Combined Authority · GBPriory Hospital Cheadle Royal · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTreating tobacco dependency in patients admitted to hospital is a key priority in the National Health Service long-term plan. This service evaluation assessed the perception, needs and experience of care within an opt-out hospital-based tobacco dependency treatment service (the Conversation, Understand, Replace, Experts and Evidence Base (CURE) team) in North-West England.

methodsA survey was offered to all eligible patients between 1 July 2020 and 30 September 2020. Eligibility criteria were adult patients identified as an active smoker being approached by the CURE team as part of the standard opt-out service model, on a non-covid ward without a high suspicion of COVID-19 infection and able to read and write in English.

results106 completed surveys were evaluated. Participants demonstrated high levels of tobacco dependency with an average of 37 years smoking history and 66% describing the onset of cravings within 30 min of hospital admission. The average number quit attempts in the previous 12 months was 1.3 but only 9% had used the most effective National Institute for Health and Care Excellence (NICE) recommended treatments. 100% felt the opt-out service model was appropriate and 96% stated the treatment and support they had received had prompted them to consider a further quit attempt. 82% of participants rated their experience of care as 9/10 or 10/10. Participants wanted a broad range of support post discharge with the most popular option being with their general practitioner. 66% and 65% of participants would have been interested in a vaping kit as stop smoking intervention and support vaping-friendly hospital grounds respectively.

conclusionThese results suggest this hospital-based, opt-out tobacco dependency treatment service delivers high-quality experience of care and meets the needs of the patients it serves. It also highlights the opportunity to enhance outcomes by providing access to NICE recommended most-effective interventions (varenicline, vaping and combination nicotine replacement therapy) and providing flexible, individualised discharge pathways.

Indexed as

COVID-19Smoking CessationAdultAftercareHospitalsHumansNicotianaPatient DischargeState MedicineTobacco Use Cessation DevicesVareniclineVareniclinetobacco and the lung

Identifiers

PMID36216401
PMCPMC9557311
OpenAlexW4304080237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.